Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Genotonorm for Corticoid-Induced Short Stature
NCT00174187Phase 3Terminated
- Sponsor
- Pfizer
- Start
- Sep 2000
- Primary completion
- Sep 2011
- Modality
- Hormone, rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 3 trial of somatropin in short stature, sponsored by Pfizer. Started Sep 2000; status: terminated.
02
Drugs
somatropin
03
Conditions
short stature
Beyond the preview
Go deeper on NCT00174187.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00174187.